Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
United Parcel Service
UPS
|
+$445M |
| 2 |
DexCom
DXCM
|
+$427M |
| 3 |
WIX.com
WIX
|
+$371M |
| 4 |
FTCH
Farfetch Limited Class A Ordinary Shares
FTCH
|
+$270M |
| 5 |
Advanced Micro Devices
AMD
|
+$265M |
Top Sells
| 1 |
Apple
AAPL
|
+$1.21B |
| 2 |
Merck
MRK
|
+$535M |
| 3 |
Microchip Technology
MCHP
|
+$526M |
| 4 |
Illumina
ILMN
|
+$473M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$455M |
Sector Composition
| 1 | Technology | 30.59% |
| 2 | Healthcare | 18.35% |
| 3 | Consumer Discretionary | 11.42% |
| 4 | Financials | 10.33% |
| 5 | Communication Services | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
526
NextEra Energy, Inc.
NEE
$146B
| $58.1M | 0.02% |
792,606
-700,938
| -47% | -$51.4M |
|
527
Insight Enterprises
NSIT
$3.96B
| $58.1M | 0.02% |
580,601
-87,913
| -13% | -$8.79M |
|
528
Assurant
AIZ
$10.6B
| $58M | 0.02% |
371,576
-13,467
| -3% | -$2.1M |
|
529
Valero Energy
VLO
$49.2B
| $58M | 0.02% |
742,937
+206,616
| +39% | +$16.1M |
|
530
Philip Morris
PM
$257B
| $58M | 0.02% |
585,290
+226,234
| +63% | +$22.4M |
|
531
Vanguard Small-Cap ETF
VB
$66.7B
| $57.9M | 0.02% |
256,860
-21,578
| -8% | -$4.86M |
|
532
ESSA Pharma
EPIX
$9.7M
| $57.7M | 0.02% |
2,017,894
+501,792
| +33% | +$14.3M |
|
533
QuantumScape
QS
$4.73B
| $57M | 0.02% |
1,948,287
+927
| +0% | +$27.1K |
|
534
Travere Therapeutics
TVTX
$2.43B
| $57M | 0.02% |
3,905,113
-245,443
| -6% | -$3.58M |
|
535
News Corp Class A
NWSA
$16.2B
| $57M | 0.02% |
2,210,383
+732,840
| +50% | +$18.9M |
|
536
Bath & Body Works
BBWI
$5.81B
| $56.9M | 0.02% |
+976,122
| New | +$56.9M |
|
537
Vontier
VNT
$6.29B
| $56.6M | 0.02% |
1,738,303
+191,026
| +12% | +$6.22M |
|
538
Criteo
CRTO
$1.18B
| $56.5M | 0.02% |
1,250,204
-239,799
| -16% | -$10.8M |
|
539
Fifth Third Bancorp
FITB
$30.1B
| $56.3M | 0.02% |
1,472,029
-168,492
| -10% | -$6.44M |
|
|
BCYC
540
Bicycle Therapeutics
BCYC
$485M
| $56.2M | 0.02% |
1,849,720
+156,062
| +9% | +$4.74M |
|
541
Colgate-Palmolive
CL
$67.2B
| $55.9M | 0.02% |
687,514
-241,819
| -26% | -$19.7M |
|
542
Grocery Outlet
GO
$1.72B
| $55.4M | 0.02% |
+1,599,693
| New | +$55.4M |
|
543
National Health Investors
NHI
$3.71B
| $55.2M | 0.02% |
823,745
+222,091
| +37% | +$14.9M |
|
544
Agilon Health
AGL
$468M
| $55M | 0.02% |
+1,356,713
| New | +$55M |
|
545
DuPont de Nemours
DD
$31.9B
| $55M | 0.02% |
710,282
+49,180
| +7% | +$3.81M |
|
|
CSW
546
CSW Industrials, Inc.
CSW
$4.24B
| $55M | 0.02% |
464,011
-14,805
| -3% | -$1.75M |
|
547
Rocket Pharmaceuticals
RCKT
$343M
| $54.7M | 0.02% |
1,235,489
-5,827
| -0.5% | -$258K |
|
548
Allstate
ALL
$52.7B
| $54.7M | 0.02% |
419,187
+26,548
| +7% | +$3.46M |
|
549
Healthcare Services Group
HCSG
$1.14B
| $54.6M | 0.02% |
1,729,306
+151,959
| +10% | +$4.8M |
|
550
Praxis Precision Medicines
PRAX
$847M
| $54.4M | 0.02% |
198,566
+127,673
| +180% | +$35M |
|